(Q53596493)

English

Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[18F]fluoroiodobenzene as radiotracers for positron emission tomography (PET).

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

Synthesis of 18F-labelled cyclooxygenase-2 (COX-2) inhibitors via Stille reaction with 4-[18F]fluoroiodobenzene as radiotracers for positron emission tomography (PET). (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

positron emission tomography

1 reference

based on heuristic

inferred from title

author name string

Frank R Wüst

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

Aileen Höhne

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

Peter Metz

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

publication date

22 December 2004

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

Organic and Biomolecular Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

503-507

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

Positron emission tomography provides molecular imaging of biological processes

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Molecular imaging in living subjects: seeing fundamental biological processes in a new light

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Positron emission tomography: the conceptual idea using a multidisciplinary approach

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Positron emission tomography scanning: current and future applications

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Accelerating drug discovery and development through in vivo imaging

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Positron Emission Tomography and Drug Discovery Contributions to the Understanding of Pharmacokinetics, Mechanism of Action and Disease State Characterization

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Drugs and probes: the symbiotic relationship between pharmaceutical discovery and imaging science

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Radiopharmaceutical chemistry for positron emission tomography

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

[(11)C] Carbon monoxide in selenium-mediated synthesis of (11)C-carbamoyl compounds

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Metabolism of fluorine-containing drugs

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Cyclooxygenase inhibitors--current status and future prospects

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Cyclooxygenase 2 inhibitors: discovery, selectivity and the future

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Cyclooxygenase 2 (COX-2) as a target for therapy and noninvasive imaging

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

COX-2 inhibitors in cancer treatment and prevention, a recent development

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Cyclooxygenase mechanisms

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Cyclooxygenase (COX) inhibitors: a comparative QSAR study

1 reference

https://api.crossref.org/works/10.1039%2FB412871K

21 January 2018

Compounds labelled with short-lived beta(+)-emitting radionuclides and some applications in life sciences. The importance of time as a parameter.

1 reference

31 May 2024

https://opencitations.net/index/api/v1/citations/10.3891/ACTA.CHEM.SCAND.53-0651

Identifiers

10.1039/B412871K

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/15678189

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53596493&oldid=2169290848"